<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>9</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2008</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Radiotherapy-related Tiredness in Patients with Glioblastoma Multiforme (GBM)</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>497</FirstPage>
			<LastPage>500</LastPage>
			<ELocationID EIdType="pii">24803</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>Tiredness may be caused by the brain injury due to the tumor or the treatment in patients with glioblastomamultiforme (GBM). Some patients describe a sense of tiredness particularly after radiation or oral chemotherapy.To evaluate tiredness level of patients with GBM during preoperative, postoperative and radiotherapy we hereeamined a sample of 38 patients. Data were collected over six months in a neurosurgery clinic. Patients assignedto Group I were given a booklet and information about radiotherapy, oral temozolomide and tiredness. GroupII received only the booklet. The chi-squared test were used to determine differences in tiredness betweenGroup I and Group II, with Spearman’s correlation for post-radiotherapy results (3 and 6 months postoperative).In conclusion, the level of tiredness was assessed to be significantly better in Group I than in Group II. Levels oftiredness in patients with GBM were greatly affected by the radiotherapy and oral chemotherapy (temozolomide).</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Glioblastoma Multiforme</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">radiotherapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">tiredness</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_24803_a8c4b04bf210a2bd4c6d40d5efe7747c.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
